Vimarsana
Biggest News Aggregation in the World

Page 45 - Testing Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Testing Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Testing Services Today - Breaking & Trending Today

CareDx, Inc (NASDAQ:CDNA) Q4 2023 Earnings Call Transcript - Vimarsana News

CareDx, Inc (NASDAQ:CDNA) Q4 2023 Earnings Call Transcript

CareDx, Inc beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.24.

CareDx, Inc (NASDAQ:CDNA) Q4 2023 Earnings Call Transcript - Vimarsana News

CareDx, Inc (NASDAQ:CDNA) Q4 2023 Earnings Call Transcript

CareDx, Inc (NASDAQ:CDNA) Q4 2023 Earnings Call Transcript February 28, 2024 CareDx, Inc beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.24. CDNA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to CareDx, Inc. Fourth Quarter […]

Source: yahoo.com
CareDx Inc (CDNA) Surpasses Revenue Expectations Despite Net Loss Expansion in 2023 - Vimarsana News

CareDx Inc (CDNA) Surpasses Revenue Expectations Despite Net Loss Expansion in 2023

Full Year Revenue Exceeds Guidance; Patent Litigation Impacts Net Loss

Source: yahoo.com
StockNews.com Initiates Coverage on Applied DNA Sciences (NASDAQ:APDN) - Vimarsana News

StockNews.com Initiates Coverage on Applied DNA Sciences (NASDAQ:APDN)

Stock analysts at StockNews.com began coverage on shares of Applied DNA Sciences (NASDAQ:APDN – Get Free Report) in a research report issued to clients and investors on Sunday. The firm set a “hold” rating on the technology company’s stock. Separately, HC Wainwright lowered their price target on shares of Applied DNA Sciences from $2.00 to […]

Myriad Genetics Inc (MYGN) Reports 11% Revenue Growth in Q4 and Full-Year 2023 - Vimarsana News

Myriad Genetics Inc (MYGN) Reports 11% Revenue Growth in Q4 and Full-Year 2023

Company Raises 2024 Revenue Guidance and Delivers Positive Adjusted EPS in Q4

Source: yahoo.com